![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 39/395 | (2006.01) |
C07K 16/28 | (2006.01) | ||
A61P 25/00 | (2006.01) |
(11) | Number of the document | 2066352 |
(13) | Kind of document | T |
(96) | European patent application number | 07802348.8 |
Date of filing the European patent application | 2007-09-11 | |
(97) | Date of publication of the European application | 2009-06-10 |
(45) | Date of publication and mention of the grant of the patent | 2015-12-02 |
(46) | Date of publication of the claims translation | 2016-03-25 |
(86) | Number | PCT/EP2007/008084 |
Date | 2007-09-11 |
(87) | Number | WO 2008/031626 |
Date | 2008-03-20 |
(30) | Number | Date | Country code |
844251 P | 2006-09-13 | US | |
06090169 | 2006-09-14 | EP |
(72) |
SACHSE, Andreas, DE
MARGOLIN, David Harris, US
|
(73) |
Alcafleu Management GmbH & Co. KG,
Lilienthalstrasse 4, 12529 Schönefeld OT Waltersdorf,
DE
Genzyme Corporation, 50 Binney Street, Cambridge, MA 02142, US |
(74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
(54) | Išsėtinės sklerozės (MS) gydymas kampatu-1H |
TREATMENT OF MULTIPLE SCLEROSIS (MS) WITH CAMPATH-1H |
Payment date | Validity (years) | Amount | |
2025-07-24 | 19 | 347.00 EUR |
2026-09-11 |